Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Phase IIa Trial Evaluating the Safety of Intratumoral Injection of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
Sponsor: NanOlogy, LLC
This PHASE2 trial investigates Locally Advanced Pancreatic Adenocarcinoma and is currently completed. NanOlogy, LLC leads this study, which shows 18 recorded versions since 2017 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
18 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2023 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
May 2022 — Dec 2023 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Dec 2021 — May 2022 [monthly]
Recruiting PHASE2
▶ Show 13 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Recruiting PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Recruiting PHASE2
-
Jul 2020 — Nov 2020 [monthly]
Recruiting PHASE2
-
Sep 2019 — Jul 2020 [monthly]
Recruiting PHASE2
-
Feb 2019 — Sep 2019 [monthly]
Recruiting PHASE2
-
Sep 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Jul 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE2
-
Oct 2017 — Dec 2017 [monthly]
Recruiting PHASE2
-
Sep 2017 — Oct 2017 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jul 2017 — Sep 2017 [monthly]
Not Yet Recruiting PHASE2
-
May 2017 — Jul 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NanOlogy, LLC
- US Biotest, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .